TSHA - TAYSHA GENE THERAPIES INC
This page shows which of the focused investors we track hold TSHA and how their positions changed, so you can see how much conviction the group has in the stock.
In Q4 2025 it was held by 1 manager with an aggregate reported value of $861.22K, which is 0.00% of the combined portfolio.
As of Q4 2025, 1 tracked institutional manager held TSHA (TAYSHA GENE THERAPIES INC) with an aggregate reported value of $861.22K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades TSHA — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q4 2025
- Ticker
- TSHA
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Polen Capital Management - Polen Capital Management | 0.00% | New | 156,586 | $861.22K |
Loading holder history for TSHA…